Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - Springer
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind …
P Ruggenenti, D Cattaneo, S Rota, I Iliev… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE To assess the effects of inhibited gastrointestinal cholesterol absorption in statin-
treated dyslipidemic patients. RESEARCH DESIGN AND METHODS In a multicenter …
treated dyslipidemic patients. RESEARCH DESIGN AND METHODS In a multicenter …
Efficacy and safety of ezetimibe and rosuvastatin combination therapy versus those of rosuvastatin monotherapy in patients with primary hypercholesterolemia
Purpose The aim of this study was to evaluate the safety and efficacy of combination
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …
Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of …
KJ Kim, SH Kim, YW Yoon, SW Rha… - Cardiovascular …, 2016 - Wiley Online Library
Aim We aimed to compare the effects of fixed‐dose combinations of ezetimibe plus
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …
Effect of ezetimibe on LDL-C lowering and atherogenic lipoprotein profiles in type 2 diabetic patients poorly controlled by statins
K Sakamoto, M Kawamura, T Kohro, M Omura… - PLoS …, 2015 - journals.plos.org
Background There exists a subpopulation of T2DM in whom first-line doses of statin are
insufficient for optimally reducing LDL-C, representing a major risk of CVD. The RESEARCH …
insufficient for optimally reducing LDL-C, representing a major risk of CVD. The RESEARCH …
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study)
HE Bays, MH Davidson, R Massaad, D Flaim… - The American journal of …, 2011 - Elsevier
The present multicenter, 6-week, randomized, double-blind, parallel-group, clinical trial
evaluated the safety and efficacy of ezetimibe (10 mg) added to stable rosuvastatin therapy …
evaluated the safety and efficacy of ezetimibe (10 mg) added to stable rosuvastatin therapy …
Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus
K Ciriacks, G Coly, S Krishnaswami… - Metabolic Syndrome …, 2015 - liebertpub.com
Objective: Statins are used to lower total cholesterol (TC) and low-density lipoprotein
cholesterol (LDL-C) levels among patients with type 1 (T1DM) and type 2 diabetes mellitus …
cholesterol (LDL-C) levels among patients with type 1 (T1DM) and type 2 diabetes mellitus …
Comparison of the efficacy and safety of rosuvastatin/ezetimibe combination therapy and rosuvastatin monotherapy on lipoprotein in patients with type 2 diabetes …
J Lee, YC Hwang, WJ Lee, JC Won, KH Song… - Diabetes Therapy, 2020 - Springer
Introduction Ezetimibe/statin combination therapy has been reported to provide additional
cardioprotective effects compared to statin monotherapy. The apolipoprotein B/A1 (apoB/A1) …
cardioprotective effects compared to statin monotherapy. The apolipoprotein B/A1 (apoB/A1) …
[HTML][HTML] Comparison of the efficacy of rosuvastatin monotherapy 20 mg with rosuvastatin 5 mg and ezetimibe 10 mg combination therapy on lipid parameters in …
YC Hwang, JE Jun, IK Jeong, KJ Ahn… - … & metabolism journal, 2019 - synapse.koreamed.org
Background The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future
cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe …
cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe …
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid‐lowering treatment strategies in diabetic subjects with and without …
JG Jimenez, JB Rosen, V Pirags… - Diabetes, Obesity …, 2013 - Wiley Online Library
Aims The objective was to assess the consistency of effect of switching to
ezetimibe/simvastatin 10/20 mg versus doubling the baseline statin dose (to simvastatin 40 …
ezetimibe/simvastatin 10/20 mg versus doubling the baseline statin dose (to simvastatin 40 …